Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Parkinson's Disease

  Free Subscription


27.06.2022

1 BMC Neurol
2 Exp Neurol
1 Int J Neurosci
2 J Neural Transm (Vienna)
1 J Neurol Neurosurg Psychiatry
7 Mov Disord
3 Neurobiol Dis
1 Neurochem Res
1 Neurol Clin Pract
1 Neurol Genet
1 Neurology
1 Neuropsychology
4 Neurosci Lett
1 Neuroscience
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. REN K, Chen Z, Ling Y, Zhao J, et al
    Recognition of freezing of gait in Parkinson's disease based on combined wearable sensors.
    BMC Neurol. 2022;22:229.
    PubMed         Abstract available


    Exp Neurol

  2. DARCY N, Lofredi R, Al-Fatly B, Neumann WJ, et al
    Spectral and spatial distribution of subthalamic beta peak activity in Parkinson's disease patients.
    Exp Neurol. 2022 Jun 19:114150. doi: 10.1016/j.expneurol.2022.114150.
    PubMed         Abstract available

  3. HUSSEIN A, Tielemans A, Baxter MG, Benson DL, et al
    Cognitive deficits and altered cholinergic innervation in young adult male mice carrying a Parkinson's disease Lrrk2(G2019S) knockin mutation.
    Exp Neurol. 2022 Jun 19:114145. doi: 10.1016/j.expneurol.2022.114145.
    PubMed         Abstract available


    Int J Neurosci

  4. OSTREA MC, Rosales RL, Joya-Tanglao M
    Efficacy and safety of apomorphine pump infusion in Filipino patients insufficiently controlled on oral anti-Parkinson medications: an open-label, pilot study.
    Int J Neurosci. 2022 Jun 20:1-10. doi: 10.1080/00207454.2022.2090352.
    PubMed         Abstract available


    J Neural Transm (Vienna)

  5. JELLINGER KA
    Morphological basis of Parkinson disease-associated cognitive impairment: an update.
    J Neural Transm (Vienna). 2022 Jun 20. pii: 10.1007/s00702-022-02522.
    PubMed         Abstract available

  6. ERRO R, Sorrentino C, Russo M, Barone P, et al
    Essential tremor plus rest tremor: current concepts and controversies.
    J Neural Transm (Vienna). 2022;129:835-846.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  7. LAWTON M, Tan MM, Ben-Shlomo Y, Baig F, et al
    Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts.
    J Neurol Neurosurg Psychiatry. 2022 Jun 22. pii: jnnp-2021-327376.
    PubMed         Abstract available


    Mov Disord

  8. WANG P, Pan J, Luo Q, Chen J, et al
    A 10-Year Community-Based Study of Leucine-Rich Repeat Kinase 2 G2385R Carriers' Conversion to Parkinson's Disease.
    Mov Disord. 2022 Jun 22. doi: 10.1002/mds.29127.
    PubMed         Abstract available

  9. STRAKA I, Svantnerova J, Minar M, Stankova S, et al
    Neurodevelopmental Gene-Related Dystonia-Parkinsonism with Onset in Adults: A Case with NAA15 Variant.
    Mov Disord. 2022 Jun 22. doi: 10.1002/mds.29125.
    PubMed        

  10. XIE A, Ensink E, Li P, Gordevicius J, et al
    Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms.
    Mov Disord. 2022 Jun 20. doi: 10.1002/mds.29128.
    PubMed         Abstract available

  11. LUO S, Goetz CG, Choi D, Aggarwal S, et al
    Resolving Missing Data from the Movement Disorder Society Unified Parkinson's Disease Rating Scale: Implications for Telemedicine.
    Mov Disord. 2022 Jun 18. doi: 10.1002/mds.29129.
    PubMed         Abstract available

  12. COKU I, Mutez E, Eddarkaoui S, Carrier S, et al
    Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's Disease.
    Mov Disord. 2022 Jun 16. doi: 10.1002/mds.29124.
    PubMed         Abstract available

  13. SCHAEFFER E, Toedt I, Kohler S, Rogge A, et al
    Reply to: "Risk Disclosure in Prodromal Parkinson's Disease".
    Mov Disord. 2022;37:1327.
    PubMed        

  14. MORRIS LA, O'Callaghan C, Le Heron C
    Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease.
    Mov Disord. 2022;37:1149-1163.
    PubMed         Abstract available


    Neurobiol Dis

  15. WILLIAMS ET, Chen X, Otero PA, Moore DJ, et al
    Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.
    Neurobiol Dis. 2022;170:105768.
    PubMed         Abstract available

  16. RAUSCHENBERGER L, Behnke J, Grotemeyer A, Knorr S, et al
    Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated alpha-synuclein mouse model of Parkinson's disease.
    Neurobiol Dis. 2022 Jun 21:105798. doi: 10.1016/j.nbd.2022.105798.
    PubMed         Abstract available

  17. ERDMAN HB, Kornilov E, Kahana E, Zarchi O, et al
    Asleep DBS under ketamine sedation: Proof of concept.
    Neurobiol Dis. 2022;170:105747.
    PubMed         Abstract available


    Neurochem Res

  18. ZAHRA W, Birla H, Singh SS, Rathore AS, et al
    Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.
    Neurochem Res. 2022;47:1816-1829.
    PubMed         Abstract available


    Neurol Clin Pract

  19. GLENARDI G, Handayani T, Barus J, Mangkuliguna G, et al
    Inhaled Levodopa (CVT-301) for the Treatment of Parkinson Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Neurol Clin Pract. 2022;12:139-148.
    PubMed         Abstract available


    Neurol Genet

  20. HILL EJ, Robak LA, Al-Ouran R, Deger J, et al
    Genome Sequencing in the Parkinson Disease Clinic.
    Neurol Genet. 2022;8:e200002.
    PubMed         Abstract available


    Neurology

  21. BERGQUIST F, Ehrnebo M, Nyholm D, Johansson A, et al
    Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease.
    Neurology. 2022 Jun 15. pii: WNL.0000000000200804.
    PubMed         Abstract available


    Neuropsychology

  22. TIMBLIN H, Rahmani E, Ryczek CA, Hill CR, et al
    Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson's disease.
    Neuropsychology. 2022 Jun 23. pii: 2022-74636-001. doi: 10.1037/neu0000837.
    PubMed         Abstract available


    Neurosci Lett

  23. XU B, Wang X, Xu Z, Li Q, et al
    N-cystaminylbiguanide MC001 prevents neuron cell death and alleviates motor deficits in the MPTP-model of Parkinson's disease.
    Neurosci Lett. 2022 Jun 20:136751. doi: 10.1016/j.neulet.2022.136751.
    PubMed         Abstract available

  24. LI C, Hou B, Li X, Yang Z, et al
    Role of CD36 rs1761667 AA genotype in the expression of inflammatory cytokines and Parkinson's disease progression: A case-control study in a northern Han Chinese population.
    Neurosci Lett. 2022;784:136736.
    PubMed         Abstract available

  25. SHI X, Zheng J, Ma J, Wang Z, et al
    Insulin-like growth factor in Parkinson's disease is related to nonmotor symptoms and the volume of specific brain areas.
    Neurosci Lett. 2022;783:136735.
    PubMed         Abstract available

  26. YANG Z, Xue L, Li C, Li M, et al
    Association between ABCA7 gene polymorphisms and Parkinson's disease susceptibility in a northern Chinese Han population.
    Neurosci Lett. 2022;784:136734.
    PubMed         Abstract available


    Neuroscience

  27. SONG J, Liu S, Lin H
    Model-based quantitative optimization of deep brain stimulation and prediction of parkinson's states.
    Neuroscience. 2022 Jun 21. pii: S0306-4522(22)00255.
    PubMed         Abstract available


    PLoS One

  28. CHONG-WEN W, Sha-Sha L, Xu E
    Predictors of rapid eye movement sleep behavior disorder in patients with Parkinson's disease based on random forest and decision tree.
    PLoS One. 2022;17:e0269392.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: